Is it anxiety or a panic attack? Discover the key differences and learn why understanding them matters for managing your ...
It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...
Most people worry, but for those with generalized anxiety disorder, worries are chronic and lead to symptoms like exhaustion, nausea, and trouble sleeping. The first step toward treatment is ...
In a world of constant connectivity and mounting pressures, generalized anxiety disorder (GAD) has emerged as a significant mental health challenge affecting millions. Recent studies show that ...
are first-line agents for all five anxiety disorders, and serotonin norepinephrine reuptake inhibitors are indicated for generalized anxiety disorder. Cognitive behavioural therapy is a gold ...
Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement ...
The acquisition also includes ITI-1284, a promising Phase 2 compound being studied in generalized anxiety disorder (GAD) and Alzheimer’s disease-related psychosis and agitation, as well as a ...
Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.
Shares of Intra-Cellular Therapies Inc. (NASDAQ: ITCI) are trading higher Monday after Johnson & Johnson agreed to acquire ...
Johnson & Johnson strengthens its neuroscience portfolio by acquiring Intra-Cellular Therapies, expanding its focus on CNS ...